UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most‐needed donors

Transfusion (Philadelphia, Pa.), 2021-01, Vol.61 (1), p.274-285

2021

Volltextzugriff (PDF)

Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

Leukemia & lymphoma, 2024-04, Vol.65 (4), p.493-502

2024

Volltextzugriff (PDF)

Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study

Leukemia & lymphoma, 2022-12, Vol.63 (14), p.3307-3316

2022

Volltextzugriff (PDF)

Hematopoietic Stem Cell Transplantation in Thalassemia

Hematology/oncology clinics of North America, 2023-04, Vol.37 (2), p.413-432

2023

Volltextzugriff (PDF)

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

Annals of hematology, 2021-02, Vol.100 (2), p.541-553

2021

Volltextzugriff (PDF)

Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation

Current opinion in hematology, 2023-01, Vol.30 (1), p.14-21

2023

Volltextzugriff (PDF)

Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioning

Transplant immunology, 2024-02, Vol.82, p.101988-101988, Article 101988

2024

Volltextzugriff (PDF)

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

Journal of hematology and oncology, 2020-07, Vol.13 (1), p.87-87, Article 87

2020

Volltextzugriff (PDF)

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Transplantation and cellular therapy, 2023-06, Vol.29 (6), p.346.e1-346.e10

2023

Volltextzugriff (PDF)

Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Transplantation and cellular therapy, 2023-06, Vol.29 (6), p.377.e1-377.e7

2023

Volltextzugriff (PDF)

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme

Annals of hematology, 2023-06, Vol.102 (6), p.1569-1579

2023

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions

Hematology/oncology clinics of North America, 2014-12, Vol.28 (6), p.1171-1185

2014

Volltextzugriff (PDF)

Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia

Cancer, 2017-09, Vol.123 (17), p.3346-3355

2017

Volltextzugriff (PDF)

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

British journal of haematology, 2016-05, Vol.173 (3), p.444-455

2016

Volltextzugriff (PDF)

Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.525-531

2014

Volltextzugriff (PDF)

Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post‐transplant cyclophosphamide in AML in first complete remission

British journal of haematology, 2023-06, Vol.201 (6), p.1169-1178

2023

Volltextzugriff (PDF)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

Frontiers in immunology, 2020-04, Vol.11, p.636

2020

Volltextzugriff (PDF)

Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely

HLA, 2017-02, Vol.89 (2), p.77-81

2017

Volltextzugriff (PDF)

Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population

Human immunology, 2021-10, Vol.82 (10), p.758-766

2021

Volltextzugriff (PDF)

Comparable Outcomes of Matched Sibling Donor and Matched Unrelated Donor Stem Cell Transplantation in Children With Acute Leukemia in Argentina

Journal of pediatric hematology/oncology, 2021-10, Vol.43 (7), p.e1020-e1024

2021

Volltextzugriff (PDF)

Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations

Transplantation and cellular therapy, 2024-09, Vol.30 (9), p.909.e1-909.e11

2024

Volltextzugriff (PDF)

High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality

Transfusion (Philadelphia, Pa.), 2024-06, Vol.64 (6), p.1068-1075

2024

Volltextzugriff (PDF)

GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT

Journal of hematology and oncology, 2023-02, Vol.16 (1), p.10-5, Article 10

2023

Volltextzugriff (PDF)

1 – 25 von 2.166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.559)
Mit Volltextzugriff
(1.870)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.918)
Science & Technology
(1.912)
Life Sciences & Biomedicine
(1.900)
Hematology
(1.400)
Unrelated Donors
(1.378)
Male
(1.167)
Female
(1.142)
Transplantation
(1.080)
Adult
(1.002)
Immunology
(998)
Middle Aged
(835)
Adolescent
(731)
Hematopoietic Stem Cell Transplantation
(608)
Oncology
(575)
Transplantation, Homologous
(568)
Child
(561)
Retrospective Studies
(553)
Stem Cell Transplantation
(496)
Treatment Outcome
(435)
Histocompatibility Testing
(433)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Biology Of Blood And Marrow Transplantation
(397)
Bone Marrow Transplantation
(303)
Transplantation And Cellular Therapy
(77)
Blood
(74)
British Journal Of Haematology
(72)
Hla
(62)
Hla : Immune Response Genetics
(62)
Haematologica
(60)
International Journal Of Hematology
(46)
Tissue Antigens
(46)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most‐needed donors

Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study

Hematopoietic Stem Cell Transplantation in Thalassemia

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation

Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioning

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme

Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions

Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage

Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post‐transplant cyclophosphamide in AML in first complete remission

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely

Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population

Comparable Outcomes of Matched Sibling Donor and Matched Unrelated Donor Stem Cell Transplantation in Children With Acute Leukemia in Argentina

Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations

High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality

GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT

Suchergebnisse filtern